Jobs für hr advisor bei Basel

ppThe actual location of this job is in Basel Tower, Switzerland. /ppAs Chief of Staff to the Chief Human Resources Officer (CHRO), you will play a key role in supporting the execution of Lonza's global HR strategy. Reporting to the Head of HR for Global Functions, and working closely with the CHRO, HR Leadership Team, and Head Transformation Orchestration,...

The actual location of this job is in Basel Tower, Switzerland. As Chief of Staff to the Chief Human Resources Officer (CHRO), you will play a key role in supporting the execution of Lonza's global HR strategy. Reporting to the Head of HR for Global Functions, and working closely with the CHRO, HR Leadership Team, and Head Transformation & Orchestration, you...

 The actual location of this job is in Basel Tower, Switzerland.As Chief of Staff to the Chief Human Resources Officer (CHRO), you will play a key role in supporting the execution of Lonza's global HR strategy. Reporting to the Head of HR for Global Functions, and working closely with the CHRO, HR Leadership Team, and Head Transformation & Orchestration,...

What Makes Cloudbeds Unique At Cloudbeds, we're not just building software, we’re transforming hospitality. Our intelligently designed platform powers properties across 150 countries, processing billions in bookings annually. From independent properties to hotel groups, we help hoteliers transform operations and uplevel their commercial strategy through...

ppbIndustry: /b Marketing Event Industrybr/bNumber of employees: /b approx 1400 worldwide / 400 CHbr/bReference number: /b 63X587WRbr/bKey Facts: /b SAP HR Ownership, SAP SuccessFactors, SAP Concur, SAP Cloud Platform integrations, project management, stakeholder management, in Basel/home office. /p h3Responsibilities /h3 ul liOwnership and operational...

Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target...

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s RD pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor;...

Oettinger Davidoff Group, with sales of over half a billion Swiss francs and over 4,000 employees around the world, traces its roots back to 1875 and remains family-owned to this day. The company is dedicated to the business of producing, marketing, distributing, and retailing premium-branded cigars, tobacco products and accessories. The premium-branded...

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor;...

Since 1967, Jet Aviation has been crafting flight in its smoothest form. From one hangar in Basel, Switzerland, to over 4,500 employees, and some 50 locations worldwide. Aircraft Management, Aircraft Sales, Charter, Completions, Government Services, FBO, Fixed and Rotary Wing Maintenance, and Staffing. Behind every seamless Jet Aviation experience, is a team...

**About This Opportunity** We're working with a leading foundational AI lab to find experienced senior medical advisors from pharmaceutical companies who can help train their latest language model on professional presentation and slide deck tasks. We're looking for senior medical advisors with 4+ years at a pharma or biotech company to create,...

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor;...